Download presentation
Presentation is loading. Please wait.
1
EPIC: Balloon Angioplasty
Primary Endpoint: Death, MI, UTVR at 30 days Placebo + heparin (ACT 300 sec) (n=696) Abciximab 0.25mg/kg bolus + heparin (ACT 300 sec) (n=395) Abciximab 0.25mg/kg bolus / 10 µg/kg infusion + heparin (ACT 300 sec) (n=708) 4.5% (P<0.004) 1.4% (P=ns) % events 12.8% 11.4% 8.3% The EPIC investigators. N. Engl J Med. 1994; 330:
2
EPIC Results 30 Day Death/MI 3.5% (P=0.015)
6 Month Death/MI 3.9% (P=0.019) 30 Day TVR 3.8% (P=0.003) 6 Month TVR 5.8% (P=0.007) 9.6% 6.1% 12.8% 8.9% 7.8% 4.0% 22.3% 16.5% 1.4% 6.6% Major TIMI Bleeding Placebo + heparin (ACT 300 sec) (n=696) Abciximab + heparin (ACT 300 sec) (n=708) % events The EPIC investigators. N. Engl J Med. 1994; 330:
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.